Introduction
============

*Campylobacter* is a leading cause of human gastroenteritis in the United States and worldwide ([@B51]; [@B261]). In the United States alone, the Centers for Disease Controls and Prevention (CDC) estimates an annual 1.3 million cases occurring per year ([@B41]). From 1999 to 2008, *Campylobacter* was estimated to cause an annual 8,463 hospitalizations and 76 deaths in the United States, along with an annual \$1.7 billion financial cost to the United States ([@B21]). In 2015, of the 4,598 hospitalizations caused by foodborne disease 1,087 were the result of *Campylobacter* ([@B39]). This burden on public health was second only to *Salmonella* when considering bacterial infections ([@B21]; [@B255]). When aggregating the loss of life and health due to illness, [@B255] determined that annually, *Campylobacter* caused 22,500 disability-adjusted life years (DALY). *Campylobacter* was ranked 3^rd^ as the leading impact of public health due to foodborne illness behind non-typhoidal *Salmonella* (32,900 DALY) and Toxoplasma (32,700 DALY). A systematic analysis from 1990 to 2013 identified *Campylobacter* as the fourth leading cause of diarrheal disease behind rotavirus, typhoid fever, and cryptosporidiosis ([@B207]). According to the World Health Organization (WHO), diarrheal diseases, viewed as a whole, cause an estimated 550 million illness each year resulting in the annual death of approximately half a million infants under the age of two ([@B316]).

In a population-based study on patients with diarrheal illness induced by *Campylobacter*, over 95% of the 1,316 cases were caused by *Campylobacter jejuni* ([@B96]). This species, along with pathogen *Campylobacter coli*, have been found in the gastrointestinal tract (GIT) of poultry ([@B304]; [@B84]; [@B40]). Broilers and layer flocks have consistently been shown to contain *Campylobacter* prevalences greater than 70% ([@B52]; [@B274]; [@B9]; [@B252]). [@B257] found that 97% of layer and 93% of broiler flocks tested positive for *Campylobacter*. Across eight flocks in the Netherlands, 55 cecal samples were taken and found that *C. jejuni* was the *Campylobacter* isolate for 100% of cecal broiler samples where in layer hens 52% were *C. coli*, 40% were *C. jejuni* (40%) and 7% were *C. lari*. Identical sequence types were found in the soil, sediment, and surface water which indicates potential contamination of the bird through environmental means. Through contamination of the poultry carcass, *Campylobacter* can cause foodborne illness and has been the etiological agent in outbreaks caused by poultry products ([@B213]; [@B100]). Therefore there is a continued urgency to implement pre- and post-harvest technologies to prevent *Campylobacter* contamination at all stages of poultry production.

With the rise of multidrug-resistant bacteria, consumer preference for antibiotic-free chicken, and government regulations such as the European Union's 2006 ban of antibiotics, alternative antimicrobials have become necessary ([@B42]; [@B144]; [@B259]). One alternative to conventionally implemented pre- and post-harvest antimicrobial strategies is the use of essential oils (EOs) ([@B282]; [@B6]; [@B35]; [@B221]; [@B280]; [@B197]). The EOs industry had a United States market share of \$6.6 billion in 2016, a 286% increase from the 2004 market share of \$2.3 billion ([@B323]; [@B106]). They are often used as flavoring agents in food products and perfumes, embalmment, anti-inflammatory and anesthesia remedies ([@B31]; [@B15]). Some EOs, such as eugenol, have been reported to have a preventative effect against cancer ([@B31]; [@B285]; [@B15]). Plant-based EOs such as eugenol, thymol, carvacrol, and cinnamaldehyde have been examined and screened for their antimicrobial properties against a number of pathogens including *Campylobacter* ([@B97]; [@B47]; [@B280]; [@B154]; [@B292]). They are also commercially attractive as alternative antimicrobials, because they are considered acceptable for organic and non-conventional applications ([@B197]; [@B211]). They may be useful not only in preventing human health-related diseases but in improving the performance of the bird ([@B3]; [@B126]; [@B66]; [@B211]). As such, the objective of this review was to discuss EOs as an intervention approach for limiting *Campylobacter* contamination in the poultry industry pre- and post-harvest. By investigating the metabolic activity of *Campylobacter*, a greater understanding of the mechanistic effects of EOs may be elucidated for more optimal application approaches in the future.

*Campylobacter* Characteristics and Metabolism
==============================================

*Campylobacter* belongs to family Campylobacteraceae, which also includes *Arcobacter* and *Helicobacter* ([@B92]). They are non-sporulating Gram-negative microorganisms, with an s-shape and cell dimensions between 0.5 and 5 μm and ranging in width from 0.2 to 0.9 μm ([@B297]). A single polar flagellum is found in 20 of the 22 species with the exception being the non-motile *C. gracilis* and *C. showae* that possess multiple flagella ([@B61]; [@B87]). *Campylobacter* spp. are microaerophilic and grow optimally in a gas composition of 5% O~2~, 10% CO~2~, and 85% N~2~, pH of 6.5 to 7.57 and from 37 to 42°C ([@B99]; [@B57]; [@B87]). *Campylobacter* will not grow at temperatures below 30°C, due to an absence of a cold shock protein gene, or with a water activity below 0.987, which is necessary to maintain turgor pressure ([@B120]; [@B58]; [@B303]; [@B179]; [@B87]). Cold shock proteins range from 65 to 75 amino acids serve as nucleic acid chaperones that prevent mRNA secondary structures from forming which enable efficient transcription and translation ([@B233]; [@B156]). Interestingly, despite the lack of a cold shock protein, biofilms of *C. jejuni* have been found to form and persist in 13°C conditions and formed biofilms with the largest surface area compared to 20, 37, and 42°C ([@B253]). Attachment of planktonic cells to the biofilms was not significantly impacted by temperature ([@B253]).

Compared to other foodborne pathogens occupying the poultry GIT, *Campylobacter* possesses a metabolism that is somewhat different and thus may be a challenge for some intervention strategies. *Campylobacter* spp. do not utilize the traditional glycolysis pathway, instead favoring amino acids such as aspartate, glutamate, serine, and proline for their cellular respiration pathways ([@B270]). The traditional glycolytic pathway is incomplete as genes encoding glucokinase and 6-phosphofructokinase are absent ([@B230]). Furthermore, despite a complete tricarboxylic acid cycle (TCA), gluconeogenesis from glucose-6-phosphate to glucose is not observed, and the genes necessary for encoding the proteins associated with the pathway are absent ([@B230]; [@B300]). Some of the gluconeogenesis and glycolysis genes and respective proteins are present which has led to the hypothesis that *C. jejuni* can catabolize intermediary molecules ([@B270]). For instance, [@B128] suggested that the presence of a glycerol-3-phosphate transporter (GlpT) in *C. jejuni* 81176 could be indicative of the breakdown of glycerol-3-phosphate to generate pyruvate and potential further breakdown through the TCA cycle. Additionally, the non-oxidative portion of the pentose pathway shunt (transaldolase, transketolase, ribulose-3-phosphate epimerase, and ribose-5-phosphate isomerase) is suggested to have the ability to metabolize pentose sugars ([@B183]).

Two studies independently identified novel l-fucose pathways with a l-fucose permease that is homologous to the one characterized in *E. coli* ([@B56]; [@B206]; [@B271]). Fucose is a component of eukaryotic glycoproteins and is found in mucin ([@B5]; [@B245]). *Campylobacter jejuni* utilizes fucose as a chemoattractant for mucin attachment ([@B133]; [@B286]; [@B98]; [@B151]). While fucose uptake was phenotypically observed in *C. jejuni* strain NCTC 11168 (isolated from human feces), it was not detected in strains 81116 and 81176 ([@B206]). This is due to the presence of a genomic island cj0480c--cj0490, which has been linked to an increase in virulence ([@B229]). [@B271] noted that this metabolic pathway improved colonization of the piglet model for human disease indicating its importance in human-associated pathogenesis. Moreover, when the l-fucose pathway genes were mutated, *C. jejuni* was still able to colonize the ceca of chickens but was outcompeted in a co-colonization experiment by the wild-type strain ([@B206]). Despite the presence of this metabolic pathway, *Campylobacter* is largely asaccharolytic and relies primarily on amino acids and organic acids for its energy and carbon needs ([@B181]; [@B270]; [@B151]; [@B154]).

Amino acids utilized by *Campylobacter* as carbon and energy sources include asparagine, glutamine, serine, aspartate, and proline ([@B317]). *Campylobacter jejuni* will preferentially utilize serine, aspartate, asparagine, and glutamate ([@B109]; [@B317]; [@B270]). [@B231] determined the most common amino acids within the ceca of leghorn hens through ion-exchange chromatography. Serine ranked 4^th^ (92.2 mmol/mol ceca content), aspartate ranked 2^nd^ (109.9 mmol/mol ceca content), and glutamate ranked 1^st^ (137.5 mmol/mol ceca content) as the most concentrated amino acids within the ceca. Asparagine, glutamine, glycine, cysteine, and tryptophan concentrations were not reported. While these concentrations will vary depending on diet, GIT microbial population, and bird type, the data provides insight into why amino acid metabolism of *C. jejuni* could play an essential role in its ecological niche within the poultry GIT ([@B239]; [@B270]). Whereas other species must rely on carbohydrate fermentation, the plentiful concentration of amino acids in the poultry ceca, due to protein-rich diets, allows *Campylobacter* to thrive ([@B145]; [@B298]; [@B123]).

Not all poultry dietary components contribute directly to the nutrition of the bird but may still interact with the GIT microbial population including resident foodborne pathogens. For example, there are primary plant compounds and secondary plant metabolites present in the poultry GIT that may not necessarily serve directly as nutrients but can still nutritionally influence bird performance ([@B266]). While some fiber components, particularly lignin, are generally considered indigestible in the avian GIT, they can still impact GIT microbial composition, alter fermentation patterns, and influence metabolite absorption ([@B243], [@B242]; [@B147]; [@B293]; [@B77]; [@B22]; [@B264]). These high fiber sources have also been shown to limit the establishment of foodborne pathogens such as *Salmonella* Enteritidis in laying hens when serving as the primary dietary source in laying hens ([@B240]; [@B315]; [@B242]). Plants also contain phenolic monomers ([@B147]). Phenolic monomers can not only cross-link carbohydrates with lignin in the plant, decreasing fiber degradation in the GIT, but in their free form can be antimicrobial to aerobic and anaerobic bacteria ([@B320]; Jung and Fahey, 1983).

Aromatic compounds can also be modified anaerobically ([@B284]; [@B216]). Often phenolic compounds such as chlorophenol and chlorobenzoate can be utilized as electron sinks, resulting in their reduction and modification within the lower GIT ([@B114]; [@B95]). While *Campylobacter* has been shown to utilize some aromatic compounds such as resorcinol and β or γ-resorcylate, this was only shown in the presence of *Clostridium* spp. ([@B284]; [@B85]). However, other aromatic compounds can be utilized as energy sources by some bacteria ([@B223]). MetaCyc identifies five complete aromatic degradation pathways present in *E. coli* including cinnamate, phenylethylamine, nitroaromatic, and phenols (version 22.5; BioCyc; Menlo Park, CA, United States) ([@B38]). Chlorobenzene, paraoxon, parathion, and shikimate degradation pathways have been identified in *L. monocytogenes* and degradation of *p*-cymene, along with other aromatic compounds, have been characterized in *Pseudomonas* spp. In *Campylobacter*, only the catechol degradation pathway has been detected. Numerous biodegradation enzymes have been elucidated in *E. coli;* for instance, eugenol has been shown to be degraded to ferulic acid by the *vaoA* gene-encoded enzymes ([@B70]; [@B222], [@B223]). However, only resorcinol, protocatechuate, and phloroglucionol degradation enzymes are known to occur in *Campylobacter* ([@B85]; [@B302]). Given the limited metabolic capacity of *Campylobacter* for modification, it would be intuitive that aromatic compounds that exhibit antimicrobial properties could effectively reduce *Campylobacter* populations in poultry production. This is important since aromatic compounds are one of the constituents present in phytobiotics.

Phytobiotics
============

Phytobiotics are plant-based compounds or extracts that have been suggested for use in commercial, and possibly organic, poultry production ([@B314]; [@B15]; [@B66]; [@B197]). Most phytobiotics are Generally Recognized As Safe (GRAS) by the [@B289] and are less toxic and typically more residual-free compared to synthetic antibiotics ([@B66]; [@B289]). Botanicals, a subset of phytobiotics, are leaves, roots, bark, or other parts of a plant, and the terminology is often used interchangeably with phytobiotics ([@B313]; [@B199]). Other types of phytobiotics include herbs, which are derived from flowering non-persistent plants, oleoresins which are non-aqueous extracts such as balsam, and EOs ([@B236]). In this review, the focus will primarily be on the activity of EOs, but other phytobiotic compounds such as herbs will also be mentioned.

Essential oils, also known as volatile or ethereal oils, are oily plant-based liquids that possess aromatic properties ([@B31]; [@B117]). The term "essential oils" was first coined by Paracelsus von Hohenheim in the 16^th^ century ([@B110]). The term 'essential' relates to the effective element in a medical preparation of the drug and is therefore loosely defined ([@B224]). Currently, there are over 3,000 known EOs with approximately 300 being commercially relevant ([@B15]; [@B66]). They include oils such as turpentine, eugenol, and cinnamaldehyde, and can be derived from other botanical compounds and herbs such as thyme, oregano, rosemary, and lemon ([@B31]; [@B89]; [@B66]). Essential oils are extracted from their corresponding plants by steam distillation, hydrodistillation, or solvent extraction which all can create a concentrate of aromatic and volatile compounds including terpenoids and phenylpropanoids ([@B208]; [@B117]; [@B238]). The concentrations of the 'essential' compounds in EOs vary wildly and are not typically defined ([@B174]; [@B24]).

Non-Antimicrobial Effects of EOs in Poultry
===========================================

Essential oils have a wide range of applications including turpentine for paint mixing or linalool and linalyl acetate that are used as alternative sleep aides ([@B30]; [@B31]). Many are incorporated as ingredients for their palatable tastes and smells in foods and aromatic sprays ([@B94]). Oregano, thyme, and cinnamon are well-known flavor enhancers ([@B157]; [@B306]). Bergamon is used for its aromatic properties of Earl Gray Tea, while synthetic based citrus oils are an ingredient in soft drinks ([@B86]; [@B103]; [@B33]). While 32.9% of EOs are applied in the food and beverage industry, the second largest application of EOs in 2015 was for spa or relaxation purposes (30.84%) ([@B106]).

In poultry, EOs have been utilized in preharvest management settings for non-pathogen related benefits ([@B66]). Digestibility of poultry feed has been shown to be improved by the addition of EOs ([@B312]). CRINA^®^ (Akzo Nobel, Crina S.A, Switzerland) is a commercial blend of EOs containing thymol, eugenol, and piperine. Broilers fed 50 mg/kg of CRINA^®^, exhibited improved activity of total amylase, trypsin, and maltase of 40kU/pancreas, 63U/pancreas, and 12.6 μM/g mucosa respectively, compared to the control group activity of 29kU/pancreas, 42U/pancreas, and 10.6 μM/g mucosa, respectively ([@B141], [@B140]). This effect was not observed; however, when 0.1% of lactate was also introduced into the diet ([@B141]). The use of 200 ppm of a blend of oregano, cinnamon, and pepper improved fecal digestibility of dry matter ([@B126]). Ileal absorption levels of amino acids such as threonine, serine, asparagine, phenylalanine, histidine, and lysine were positively improved by 7.8 and 8.8% by the addition of 150 and 300 ppm of a plant extract containing capsaicin, carvacrol, and cinnamaldehyde ([@B138]).

Amino acid absorption studies have also been performed using rat intestines. A catheter was attached to both ends of a sector of the jejunum of anesthetized rats ([@B166]). In the treatment groups, the jejuna were preincubated with 1000 ppm cinnamaldehyde or 850 ppm of eugenol or a saline control. Alanine was then fed through the jejuna, and it was observed that after 40 min the jejuna preincubated with cinnamaldehyde and eugenol absorbed 22 to 25 nmol of alanine compared to 60 nmol in the control. This suggests reduced nutrient absorption ([@B166]; [@B174]). However, conclusions drawn from this study may be difficult to apply to production animals due to the high concentrations necessary in the feed to result in similar concentrations in the GIT as utilized in [@B166]. [@B176] observed that 100 ppm of thymol or cinnamaldehyde exhibited no significant effect on pancreatic digestive enzyme activity at day 21 or day 40 within female broilers ([@B174]). This study shows that thymol alone is unable to impact pancreatic digestive enzymes within poultry and a combination of multiple EOs, such as in [@B141], [@B140], may be necessary to impact digestibility responses in broilers. However, it may be specific combinations of EOs that impact digestibility and nutrient absorption.

Improvements in nutrient absorption and digestibility can result in improved growth rates within broilers ([@B104]). Feed conversion ratio (FCR), the ratio between feed intake and average weight gain, is one of the more commonly used metrics to determine if a feed additive is beneficial to commercial livestock production ([@B177]). Several studies have reported no improvement in growth rate or FCR when diets have been supplemented with EOs ([@B176]; [@B141], [@B140]). However, FCR and body weight gain (BWG) improvements have been observed in other studies that utilized EOs ([@B64]; [@B32]; [@B20]). [@B32] demonstrated that 24 or 48 mg/kg of Heryumix^TM^ significantly improved FCR on days 21 to 1.53 and 1.56 compared to the control at 1.62. On day 42, compared to the control at 1.87, the FCR was also improved to 1.80 and 1.77 with 24 or 48 mg/kg of Heryumix^TM^ ([@B32]). Heryumix^TM^ is composed of oregano, laurel leaf, sage, myrtle, fennel, and citrus peel extracts (Herba Gida Maddeleri; Seferihisar, Turkey). [@B64] observed similar improvements in quail when their diet was supplemented with 60 mg/kg of thyme or black seed oil.

This discrepancy may be due to certain variables including bird type, feed composition, and EO type. The intestinal mucosa and GIT microbiome composition of birds vary depending on the species and age of the bird ([@B322]; [@B272]). While the phyla *Bacteroidetes* and *Firmicutes* are dominant within quail and broiler chicken cecal microbiomes, the represented genera are different ([@B219]; [@B184]). Over 117 different genera were identified by [@B308] in broiler chicken ceca. The quail microbiome, however, is not as taxonomically rich at the genus level with only 32 genera being detected by [@B311]. Furthermore, while the top five most dominant genera based on taxa analyses were *Lactobacillus, Rumiunoccocus, Clostridium, Bacteroides, Faecalibacterium* in the chicken cecal microbiome, the quail ceca microbiome was dominated by *Bacteroides, Ruminococcus, Faecalibacterium, Enterococcus*, and *Clostridium* ([@B308]; [@B311]). These microbiome differences along with unknown host-species interactions should be considered when evaluating and comparing the effectiveness of any particular feed amendment across species ([@B165]).

Additionally, the feed may play a major role in how EOs improve FCR. As elucidated in [@B138], EOs can impact the absorption of amino acids and potentially other nutrients in the ileum. As a consequence, the FCR should be improved in birds on typical commercial diets amended with EOs. Furthermore, improved absorption of amino acids could conceivably also allow for the use of non-conventional diets that contain less protein. In-depth studies employing not only commercial bird performance measurements but intestinal pathway and tissue profiling to screen and compare feed composition and EO blend combinations would be necessary to address this hypothesis.

Finally, while terpenoids are the main constituents of EOs, their chemistry can vary widely ([@B136]). For instance, carvacrol is a monoterpene alcohol and, in rats, its aliphatic group readily undergo aromatic hydroxylation while its alcohol group undergoes carboxylation ([@B137]; [@B136]). Thymol on the other hand forms derivatives of benzyl alcohol and 2-phenylpropanol when reduced ([@B12]). When carvacrol was fed to rats, their excreted urine contained more of 2-(3-Hydroxy-4-methylphenyl)propan-2-ol then carvacrol but when thyme was fed to rats it was in the highest concentration out of its five derivates ([@B12]). This suggests, in rats, that carvacrol undergoes chemical interactions and is metabolized more than thymol. This functional difference between EO metabolism, along with the importance of bird type and feed composition, may in part explain the variation in EOs benefit to broiler nutrition.

Although there is variation in EOs benefit to poultry growth, the antioxidant activity of many EOs is well-known ([@B18]; [@B249]; [@B192]). Rosemary oil, thymol, carvacrol, oregano, ginger, and coriander all possess antioxidant activity ([@B307]). An oxidation deterioration test involving the application of EOs to lard indicated that 0.20% oregano possessed the most antioxidant capacity followed by thyme, dittany, marjoram, spearmint, then lavender ([@B78]). [@B78] also found that combinations of thyme and marjoram and thyme and spearmint EOs also had potential synergistic properties in protecting lard from oxidation. These properties benefit bird health and can be marketable if EOs are used on the finished product ([@B175]; [@B66]).

Additionally, the sensory characteristics of EOs mean that they can enhance the sensory characteristics of the final products if used in the appropriate concentrations. The addition of 300 mg/kg of oregano, garlic, or an equal combination in the diets was shown to significantly improve the flavor of frozen chicken breasts up to 60 days ([@B158]). Birds fed the EOs were processed, and the breasts were stored at -25°C for sensory analysis. Overall flavor evaluated on days 1, 15, and 30 indicated that all EOs treatments scored significantly higher than the control. Overall acceptability scores of breast meat indicated that only garlic resulted in a more palatable final product on days 1, 15, and 30. Overall acceptability scores were based on flavor, appearance, and tenderness. Days 45 and 60 scores were not analyzed statistically due to spoilage. On organic seabass filets, the addition of 0.2% thyme oil improved the sensory characteristics ([@B164]). A panel of seven judges evaluated the filets on nine days within a 21-day storage trial where the filets were held at -30°C. While the control group reached the acceptability limit on taste in 6 days the addition of 0.2% thyme improved the sensory characteristics scores extending shelf life by 2 days. When the filets were placed in modified atmospheric packaging (MAP) (60% CO~2~; 30% N~2~; 10% O~2~), sensory characteristics were improved to allow for a shelf life of 14 days. When thyme oil was added to the MAP, shelf life was extended by 3 days. Despite these potential benefits, their antimicrobial activities might be some of their more important attributes to commercial poultry production.

Antimicrobial Mechanisms of Essential Oils
==========================================

Indirect Antimicrobial Mechanisms
---------------------------------

There are indirect characteristics associated with the presence of EOs that may play a role in reducing *Campylobacter* and other pathogen loads on the final poultry meat product. While no definitive mechanism has been elucidated, there have been several potential antimicrobial outcomes that may indirectly impact *Campylobacter*. For instance, the improved ileal absorption of amino acids within broilers, as demonstrated by [@B138], may limit a required nutrient source for *Campylobacter* in the ceca ([@B299]). Improvement of the immune response may also impact pathogen concentrations ([@B66]). Layer hens exhibited improved antibody titer levels to Newcastle disease and infectious bursal disease when their diets were supplemented with Heryumix^TM^ ([@B225]). In another study with Heryumix^TM^, the humoral immune response of layer hens in heat stress was not stimulated ([@B28]). [@B20], noted that broilers fed 0, 250, or 500 mg/kg of oregano exhibited IgG concentrations of 27.42, 30.50, and 39.41 mg/dL, respectively. The IgM concentrations were 7.91, 9.58, and 11.71 mg/dL, respectively ([@B20]). However, while these concentrations of antibodies were higher, they were not statistically significant (*P* \> 0.05) ([@B20]). As such, further research should be conducted to elucidate the mechanism(s) of EOs on the poultry immune system. Understanding how EOs improve the immune system of poultry may be important because *Campylobacter* colonization may elicit an immune response, and therefore there is potential to reduce *Campylobacter* concentrations through immune system modulation ([@B50]). Essential oils may also interact with *Campylobacter* populations directly.

Direct Antimicrobial Mechanisms
-------------------------------

Much of the mechanisms associated with antimicrobial activities of EOs have been elucidated from microorganisms other than *Campylobacter*, and thus assumptions regarding *Campylobacter* must be inferred to some extent. General antimicrobial mechanisms associated with EOs have been extensively described previously by [@B221] and will be discussed briefly in the current review with specific emphasis on *Campylobacter* where applicable. Essential oils have been shown to alter proteomes and cell morphology of pathogenic bacteria ([@B215]; [@B221]). Significant morphological differences in cell shape have been observed when EOs such as mint, thymol, and cinnamaldehyde have been applied to bacteria ([@B170]; [@B150]; [@B115]). For instance, the use of cinnamaldehyde on *Bacillus cereus* inhibited cell division resulting in elongated filamentous cells that were clumped together with incomplete septa ([@B170]). After 1 h, almost all cells were in filamentous chains with no clear septas. *Salmonella enterica* serovar Thompson grown in the presence of a sub-lethal concentration of thymol (0.01%) demonstrated an altered proteomic profile compared to the control, which included downregulation of binding and chemotaxis proteins, but resulted in upregulation of other outer membrane proteins ([@B65]). In-depth analysis using 2-D PAGE, followed by MALDI-TOF, revealed that GroEL and DnaK were upregulated in the presence of thymol. GroEL, along with GroES, as well as DnaK, along with DnaJ, prevents misfolding and proper indiscriminate assembly of polypeptides under stress conditions within the cytoplasm ([@B88]; [@B205]). Changes in regulation were detected by spot detection, and the relative size of the GroEL spot was 0.109 units in the control compared to a spot size of 1.044 units. The DnaK spot was not detected in the control but exhibited a size of 0.267 in the treatment with thymol. Other downregulated proteins include CheW, which is involved in transferring sensory signals from chemoreceptors to flagellar motor proteins, and thioredoxin docking proteins (Trx1). The spot size of CheW was 0.153 units and was not detected in the thymol treated cells where the Trx1 spot was 0.223 units in the control and not detected in the thymol treatment. Trx1 is an active oxidation--reduction protein that has been found to be involved in cell division in *E. coli*, which suggests thymol may play a role in the inhibition of bacterial population growth ([@B168]). Trx1 refolds citrate synthase, an essential enzyme in the TCA cycle, and by downregulating Trx1 with thymol, citrate synthase was not present. In addition, enzymes of the reverse TCA cycle were upregulated in the thymol treatment such as an increase of citrate lyase from 0.08 units to 0.654. Acetate kinase was also reduced from 0.567 units to 0.19 units within *Salmonella*. These results may not be replicated in *Campylobacter* due to its incomplete glycolytic pathways and studies investigating the use of EOs to alter the proteome of *Campylobacter* should be performed.

Another proposed mechanism for the effect of EOs on bacteria such as *Campylobacter* is their potential to disrupt the outer membrane and initiate cell lysis ([@B221]). Attributed largely to EOs hydrophobicity, the outer membrane lipids may be disrupted, sheared, or penetrated, allowing for an increase in permeability ([@B90]; [@B29]; [@B111]). Carvacrol and thymol, in 200 mg/L concentrations, have been demonstrated to inhibit *E. coli* through fluorescent flow cytometry ([@B318]). The mechanism proposed in this study, supported by [@B121], was that EOs disrupt the lipopolysaccharides membrane structure and alter the proton gradient ([@B318]). This effect may not occur in *Campylobacter* spp. due to their reliance on fermentation pathways and would have to be investigated ([@B183]). Alterations of the lipopolysaccharide membrane can still lead to disruption of the cytoplasmic membrane and cell lysis ([@B318]). Electron microscopy has demonstrated the *E. coli* treated with oregano oil resulted in cell membrane collapse and leakage of contents ([@B262]; [@B59]). Cumin derived *p*-cymene has been demonstrated to swell bacterial cell membranes and has been suggested to be used synergistically with carvacrol to lyse bacterial membranes ([@B290]). Other phenolic compounds have been observed to demonstrate this effect on the bacterial membrane ([@B53]; [@B146]; [@B172]; [@B29]).

Essential oils have also been shown to impact Gram-positive organisms ([@B260]). Cinnamaldehyde and eugenol, only when used in combination, were shown to inhibit *Staphylococcus, Micrococcus*, and *Bacillus* ([@B200]). Moreover, when considering the 300 commercially viable EOs, it is quite likely not all EOs may operate under the same mechanism ([@B66]). They may even operate in concert with a series of mechanisms that represent contradictory activities against bacterial cellular processes. While some EOs blends promote the growth of beneficial bacteria others have inhibited beneficial bacteria such as *Lactobacillus*, and even some *Bacillus* species ([@B159]; [@B190]; [@B62]; [@B138]; [@B73]). Furthermore, the antimicrobial activity may not be attributable to one specific mechanism ([@B265]; [@B37]). When considering all of the proposed mechanisms it seems more than likely that multiple mechanisms are responsible for the effect of EOs against pathogens including *Campylobacter* ([@B66]). As a consequence, the impact of EO blends on *Campylobacter* populations may vary considerably in pre and post-harvest applications.

Antimicrobial Effects of EOs on *Campylobacter* in Poultry Pre-Harvest Environments
===================================================================================

Transmission and Colonization of *Campylobacter* in the Poultry GIT
-------------------------------------------------------------------

The use of EOs in pre-harvest environments has focused on preventing pathogen colonization or reducing their concentration in the GIT ([@B29]). *Campylobacter* resides in the intestinal mucosa of the avian GIT and can be rapidly transmitted throughout a flock via the drinking water and fecal-oral route ([@B203]; [@B23]; [@B153]). *Campylobacter* virulence factors that impact colonization include, *motA, fliA, jlpA*, and *racR* and were discussed in [@B292] and reviewed in [@B27]. While there is still controversy over how and when *Campylobacter* colonize the ceca, the most common route is believed to be horizontal transmission throughout the flock ([@B55]; [@B263]). Vertical transmission has been reported from parent to fertile egg and studies have detected 35% inoculation of the progeny ([@B49]; [@B48]; [@B55]). However, in a study with 60,000 progeny-parent breeders there was no evidence of vertical transmission, and therefore more emphasis is placed on *Campylobacter* colonization occurring through horizontal or environmental transmission ([@B34]; [@B263]). *Campylobacter* can spread through water supplies, insects, litter, rodents, fecal content, and from bird to bird contact ([@B1]; [@B2]; [@B131]). *Campylobacter* colonization is usually detected at approximately 3 weeks of age and with concentrations rapidly reaching 10^7^ CFU/g ([@B52]). The ceca, containing up to 10^9^ CFU/g, contains the largest concentration of *Campylobacter* within the avian GIT due to the abundance of nutrients, including amino acids, and the temperature in the avian ceca being approximately 42°C, which is optimal for *Campylobacter* growth ([@B273]; [@B101]; [@B283]). The ceca are closed pouches between the ileum and the colon ([@B76]). This site is an important consideration for food safety as the ceca may rupture during poultry processing leading to contamination of the finished poultry product if not properly handled ([@B119]).

EOs and *Campylobacter* in the Ceca
-----------------------------------

When examining responses of cecal contents *in vitro*, 20 mM (approximately 0.3%) of cinnamaldehyde, thymol, eugenol, or carvacrol were all independently effective in significantly reducing *Campylobacter* concentrations after 15 s of incubation ([@B162]). By 8 h incubation, 10 mM concentrations of cinnamaldehyde, thymol, eugenol, or carvacrol were sufficient in decreasing *C. jejuni* by at least 5-log colony forming units (CFUs)/mL ([@B162]). [@B169] spiked 3 × 10^8^ CFU/ml of *C. jejuni* C338 into 20-day old chicken cecal contents that previously contained no detectable *Campylobacter.* One gram of cecal contents was mixed with 19 mL of an anaerobic media containing 0.05 or 0.025% lemon myrtle oil. The media comprised of MgSO~4~7H~2~O, 0.5 g; CaCl~2~, 0.02 g; K~2~HPO~4~, 0.75 g; NaH~2~PO~4~H~2~O, 0.25 g; yeast extract 1.0 g; resazurin, 1 mg; and cysteine-HCl, 0.5 g per liter of deionized water was kept in an anaerobic chamber ([@B171]). Cultures were incubated for 48 h at 39°C and plated. While the positive control retained a concentration of 6.11 log CFU/mL, broths containing EOs reduced *Campylobacter* concentrations below the limit of detection (less than 3.3 log CFU/mL).

Caprylic acid, a component of coconut oil and palm kernel oil, significantly reduced *Campylobacter* cecal concentrations when administered in feed at concentrations below 1% ([@B186], [@B187]). This was observed in market age and 10-day old broilers and did not affect FCR or BWG. However, the *in vivo Campylobacter* reducing effects of caprylic acid have been demonstrated to be mitigated when applied as caprylate in feed and water ([@B122]; [@B194]).

[@B10] investigated the use of thymol, carvacrol, or a combination, as a feed amendment to prevent *C. jejuni* colonization. Ten birds per treatment were inoculated on day 3 with a 5-strain mixture of *C. jejuni* that were previously isolated from chicken ceca and susceptible to ciprofloxacin or fluoroquinolone. Birds were euthanized on day 10. Cecal *Campylobacter* counts were enumerated using *Campylobacter* Line agar ([@B182]) and confirmed using latex agglutination. Individual strains were not distinguished. Four trials were performed of this experiment with the only difference between trials was the inclusion of a 2% (Trials 1 and 2) or 0.125% treatment group and the use of EO combinations (Trials 3 and 4). While significant reductions of *Campylobacter* in the 0.25% thymol, 2% thymol, 1% carvacrol, and 0.5% thymol and carvacrol treatments existed, these reductions were not observed across all trials and were not detected in birds fed other concentrations. Thymol, at a concentration of 0.25%, reduced *Campylobacter* by 0.6 log CFU/mL cecal contents during only one trial out of four. A 2 log CFU reduction was observed with 2% thymol for only one trial out of two. Additionally, 2 log CFU/mL cecal contents were observed for one trial using 0.5% thymol and carvacrol, but this was not repeated.

*Campylobacter jejuni-*infected broilers in a seeder model that were given feed coated in 0.3% trans-cinnamaldehyde did not exhibit any significant reduction in *Campylobacter* cecal populations after 1 week ([@B124]). In this model, six pens were set up each containing nine chickens with half of the pens receiving cinnamaldehyde. At day 15, three chicks per pen were given 10^8^ CFU/mL of *C. jejuni* KC 40. At day 21, the chickens were euthanized. All ceca within the treatment groups contained *C. jejuni*. When the cecal populations of *Campylobacter* were averaged per pen, significant differences between treatment and control group were not observed. Cinnamaldehyde degrades quickly in the upper GIT of piglets, and this may explain the lack of differences within the populations for the chicken-based studies as well ([@B198]). A commercial blend of garlic and cinnamon, Alliin Plus (Orffa, Werkendam, Netherlands), was found to cause a 1 log CFU/g reduction of *Campylobacter* cecal counts 3 days post-infection (day 11) but no significant effects were detected on day 35 or day 42 ([@B113]).

Combinations of EOs and Other Antimicrobial Compounds
-----------------------------------------------------

Numerous alternative antimicrobials have been implemented in pre-harvest poultry environments to inhibit foodborne pathogens such as *Campylobacter* ([@B291]). These include bacteriophages, bacteriocins, prebiotics, probiotics, and organic acids (OAs), and EOs ([@B294]; [@B79]; [@B291]). With different mechanisms of action, these remediation techniques may have synergistic potential. As such, this section will review combinations of EOs and other alternative non-EO antimicrobials, notably OAs against *Campylobacter*.

[@B105] evaluated the effectiveness of a 0.03% blend of thymol, eugenol, piperine, and benzoic acid or 0.08% garlic oil. Chickens were inoculated with 0.1 mL of 10^5^ CFU/mL of *C. jejuni* at day 14 by [@B105]. On days 21 to 42, birds in treatment groups were administered the EOs benzoic acid blend or garlic oil. In the control groups, *C. jejuni* populations were 7.33 and 7.38 log CFU/g. In the treatment group with the EOs blend, concentrations of *C. jejuni* were 7.66 log CFU/g, and in the garlic oil treatment, *C. jejuni* concentrations were 7.26 log CFU/g. Both these treatments were not able to statistically reduce *Campylobacter* concentrations.

An OA and EO treatment combination was administered to broilers by [@B279]. This blend contained sorbate, fumarate, and thymol. Sorbate has been demonstrated to disrupt the cell wall of Gram-negative bacteria and lower pH of the GIT, while fumarate indirectly affects intestinal bacteria by lowering the pH of the stomach ([@B67]; [@B227]; [@B69]). Because these OAs operate differently than the proposed EO mechanism, they may have synergistic potential, although fumarate has been demonstrated to be metabolized by *C. jejuni* ([@B127]). Feed was amended with 500 ppm of the EOs-OA blend and provided to broilers ([@B279]). On day 14, these birds were administered 1 mL of inoculum containing 10^5^ CFU/mL of two strains of *Campylobacter* (designated \#1 and 2). One, two, and three weeks after inoculation *Campylobacter* concentrations were enumerated in the ceca and on the whole carcass post-processing. This experiment was repeated using a different set of strains (3 and 4) with lower adhesion properties. In the trial with strains 1 and 2, counts of *Campylobacter* were not significantly different when compared to the control. In the trial with strains 3 and 4, cecal populations were significantly higher 3 weeks after inoculation by approximately 1.5 log CFU/g, but carcass rinses were significantly lower by approximately 2 log CFU/mL. This suggests the adhesion properties may impact the efficacy of the EO treatment, however other variations between the strains may be impacting the results. These adhesion properties are necessary for binding to the intestinal cell wall within poultry, which may also be impacted by EOs ([@B301]).

Impacts on the Intestinal Mucosal Layer and Microbiota
------------------------------------------------------

The proposed mechanism of protecting the intestinal mucosa from colonization has been demonstrated by studies involving prebiotics, which are typically oligosaccharides utilized for the protection of the mucosal layer or improvement of the colonization of beneficial bacteria ([@B173]; [@B301]; [@B143]; [@B248]; [@B196]; [@B241]). The intestinal mucosa consists of the epithelium and lymphoid tissue along with the mucus that is primarily comprised of glycoproteins referred to as mucins ([@B201]). Mucins range from 0.5 to 20 Mda in size, and the saccharide component of the avian mucins includes fucose (15.29 ng/μg of mucin), *N*-acetyl-galactosamine (5.3 ng/μg), *N*-acetyl-glucosamine (47.72 ng/μg), galactose (24.67 ng/μg), glucose (5.15 ng/μg), and mannose (15.44 ng/μg) ([@B16]; [@B185]). These carbohydrates comprise 80% of the glycoprotein weight and are oligosaccharide chains consisting of 5 to 15 monomers attached to the protein core ([@B16]). Approximately 60% of the protein core consists of serine, threonine, and proline repeats and this is interspersed with approximately 10% cysteine and connect to the oligosaccharide chains via O-glycosidic bonds ([@B232]; [@B102]; [@B16]).

Mucus protects the GIT epithelial layer from exposure to the digestive enzymes and corrosive gastric fluids and serves as a matrix for the entrapment of bacteria ([@B287]; [@B232]; [@B180]). For instance, [L]{.smallcaps}-fucose, serine, and cysteine of mucins have been demonstrated to exhibit a positive chemotaxis response on *C. jejuni*, attracting the bacteria to the chemical compound ([@B133]). *Campylobacter jejuni* have also been found to preferentially attach to avian mucins compared to cow, deer, horses, mice, sheep, pigs, and rat mucins ([@B212]). These entrapped bacteria can, in turn, modulate gene expression of epithelial cells, impact lymphoid cells, and affect the overall health of the host by degrading complex oligosaccharides and producing short-chain fatty acids (SCFAs) ([@B130]; [@B108]; [@B258]). In chickens, the intestinal microbiota within this mucosal layer is diverse and complex, and in the ceca, the microbiome is primarily colonized by *Firmicutes, Bacteriodetes*, and *Proteobacteria* ([@B308]).

Detectable *Campylobacter* colonization usually occurs after 14 days of age and growth is often correlated with the presence of other microbiota, although *Campylobacter's* interaction with the microbiome is poorly characterized ([@B125]; [@B135]; [@B280]). In humans, *C. jejuni* colonization is associated with a decrease of the butyrate producer, *Faecalibacterium*, which suggests these two bacteria may share a similar ecological niche ([@B116]; [@B280]). Lower abundances of *Lactobacillus* and *Corynebacterium* have also been associated with *C. jejuni* colonization, along with higher concentrations of *Streptococcus* and *Ruminococcaceae* ([@B149]). These findings indicate that there is an interaction between the intestinal microbiota and *C. jejuni* colonization. Therefore, utilizing EOs to alter the mucosal layer, possibly through microbiome modulation, or interfering with *C. jejuni* binding properties, would be beneficial to preventing intestinal colonization and downstream product contamination.

One mechanism for bacterial adhesion to the poultry GIT is through lectin-carbohydrate receptors ([@B301]). Mutants of *C. jejuni* without CadF protein synthesis capabilities are unable to produce a lectin protein that specifically binds to fibronectin ([@B321]; [@B250]). CadF is a membrane-bound protein that mediates the binding of *Campylobacter* to fibronectin within the intestinal mucosa, which is necessary for *Campylobacter* colonization ([@B237]; [@B321]; [@B202]). CadF operates by modulating the level of tyrosine phosphorylation of paxillin, which is a focal adhesion signaling molecule ([@B163]). These mutants were unable to colonize the poultry GIT, because of the absence of the carbohydrate binding adhesion protein ([@B321]). [@B235] postulated that oligosaccharides, such as mannan-oligosaccharides, would bind to enterocyte receptors on pathogenic cell walls which would also prevent colonization ([@B196]). Essential oils have not yet been found to inhibit colonization of *Campylobacter* through preventing lectin-carbohydrate binding.

Similar to prebiotics, such as pectin and oligosaccharides, EOs have been shown to improve the qualities of the mucosal layer of the intestine ([@B25]; [@B301]; [@B305]). As with EOs impacting the immune response in layer hens against NCV, prebiotics has been shown to upregulate immune response cells in the intestinal mucosal such as CD4+ and CD8+ ([@B188]). Immune responses by prebiotic supplementation have been extensively reviewed in [@B118]. Additionally, mucins, which can subvert the adherence of pathogenic *E. coli* have been upregulated by *Lactobacillus plantarum* 299V and *Lactobacillus rhamnosus* GG ([@B189]; [@B118]). *Lactobacillus* can be promoted by prebiotics and potentially EOs, and this can potentially create a positive feedback loop as mucins have also been demonstrated to improve bacterial growth as they can be up to 90% carbohydrate by weight ([@B232]; [@B191]; [@B80]; [@B82]; [@B118]; [@B319]).

The influence by EOs on the intestine has primarily focused on crypt depth and mucosal thickness ([@B301]). Broiler diets supplemented with 100 mg/kg of 5% carvacrol, 3% cinnamaldehyde, and 2% of capsicum oleoresin exhibited an impact on the jejunal mucosa. A higher jejunal wall villi layer was observed along with an increase in thickness of the mucosa layer, which helps prevent bacterial colonization ([@B139]). This is because while the thicker mucosa may potentially entrap more bacteria, a thick mucosal layer may also prevent adhesion to the intestinal villi and subsequent GIT colonization by decreasing the proximity of bacteria to the intestinal binding sites ([@B288]). Broilers supplemented with thymol or garlic powder (1 g/kg) in their diet showed similar effects in the intestinal morphology ([@B63]). However, in pigs, villi length was either decreased or unaffected by supplementation of EOs ([@B209]; [@B218]; [@B167]). Prevention of bacterial adhesion would be beneficial for inhibiting *Campylobacter* but could have deleterious effects on nutrient absorption due to changes within the GIT microbial community. For instance, SCFA producing bacteria, such as *Lactobacillus* and *Bifidobacterium*, have been shown to have positive impacts on nutrient absorption and overall bird health and antimicrobial strategies that prevent their growth could be detrimental. However, EOs have been reported to improve the colonization of bacteria that are non-pathogenic and may benefit the overall health of the microbiota ([@B309]; [@B314]).

Growth rate improvement of *Lactobacillus, Bifidobacteria*, and other probiotic bacteria in avian hosts is viewed as a potential mechanism inhibiting avian colonization of foodborne diseases such as *Campylobacter* ([@B254]). In simulated environments, *Lactobacillus* has been shown to inhibit the colonization of undesired bacteria such as *Campylobacter* ([@B44]). Four strains of *Lactobacillus* (10^4^/ml) and *C. jejuni* (10^6^/mL) were added to a simulated chicken digestive system consisting of pH adjusted veronal buffers. Veronal buffer contains 0.15 mM CaCl~2~, 141 mM NaCl, 0.5 mM MgCl~2~, 0.1% gelatin, 1.8 mM sodium barbital, and 3.1 mM barbituric acid (Sigma-Aldrich; St. Louis, MO, United States) and was subsequently adjusted to a pH of 4.5, 4.4, 2.6, 6.2, and 6.3 to represent the crop, proventriculus, gizzard, small intestine, and large intestine, respectively. A simulated chicken digestive system was also created by adjusting each veronal buffer with 0.1N HCl or with veronal buffer at pH 9.6 to simulate passage within each intestinal organ. Within individually simulated GIT compartments, and the simulated chicken digestive system as a whole, significant *Campylobacter* reductions were observed compared to the control with no addition of *Lactobacillus*. In the gizzard, while a reduction from approximately 6 log CFU/mL to approximately 4 log CFU/mL of *Campylobacter* was observed within 90 min, likely due to the low pH, a 4 log reduction was observed when 6 log CFU/mL of *Lactobacillus* was added. These results might in part be due to the ability for *Lactobacillus* to produce bacteriocins that are inhibitory to *C. jejuni* ([@B193]). [@B275] applied purified bacteriocin OR-7, produced by *Lactobacillus salivarius* NRRL B-30514, to the feed of broilers that were challenged with *C. jejuni*. Compared to controls, 6 log CFU/g cecal content reductions were observed independently of the *C. jejuni* strain utilized.

*Lactobacillus* has also been known to produce SCFAs that can reduce *C. jejuni* populations ([@B13]). When SCFAs were tested *in vitro*, butyrate was determined to be bactericidal toward *C. jejuni* at a concentration of 12.5 mM, and acetate and propionate were bacteriostatic at 50 mM ([@B295]). *Campylobacter* has been demonstrated to produce acetate as a by-product of serine catabolism and utilize it as an energy source, which could explain the variation between it and butyrate inhibition ([@B228]; [@B270]). This does not explain the variation between propionate and butyrate. While it has been demonstrated that *C. jejuni* can metabolize acetate and the OA lactate, no known pathways have been elucidated for the transport or metabolism of propionate or butyrate ([@B317]; [@B281]; [@B7]).

*Lactobacillus* and *Enterococcus* strains, which can produce SCFAs, were tested *in vitro* and were also found to be inhibitory to *C. jejuni* ([@B46]; [@B4]). [@B46] cultured five *Enterococcus* and five *Lactobacillus* strains from healthy chickens and grew them in Mueller-Hinton broth. The broth was subsequently centrifuged, and the supernatant was separated from the bacteria. The supernatant was neutralized to a pH of 6.2 and treated with pronase and catalase to break down bacteriocins and hydrogen peroxide, respectively. Once the supernatants were confirmed to be free of bacteria, they were applied in a well-diffusion agar assay against 10 individual strains of *C. jejuni*. The supernatant with the highest bactericidal activity came from a *Lactobacillus* strain labeled P93, which produced a zone of inhibition of 9 to 15 mm and was able to impact the growth of all 10 strains of *C. jejuni*. This strain was also grown in co-culture with *C. jejuni* C2150, each at an initial inoculum of 7 log CFU/mL, and after 48 h, *Campylobacter* was not isolated from the culture. *Campylobacter jejuni* C2150 was also grown with *Lactobacillus* strain P104, which did not exhibit any antimicrobial effects in the well-diffusion agar, but by 72 h *Campylobacter* concentrations were approximately 1.5 log CFU/mL lower than the positive control at 7.5 CFU/mL. This study indicates that not only can *Lactobacillus* directly compete for nutrients and colonization niche with *Campylobacter*, but some strains can also employ antimicrobials to reduce their population numbers further.

Plant-derived compounds such as cumin, oregano, and extracts of capsaicin, cinnamaldehyde, and carvacrol have been shown to improve the growth of *Lactobacillus, Bifidobacteria*, and *Enterococcus*, and therefore may indirectly impact pathogen concentrations through competitive exclusion ([@B159]; [@B138]; [@B191]). [@B190] demonstrated how XT, a mixture of carvacrol, cinnamaldehyde, and capsaicin, increased *Lactobacillus* cecal counts in post-weaning pigs when provided in the feed. However, these interactions are complicated as the addition of *C. jejuni* has been attributed to an increase in *Bifidobacterium* ([@B280]). Further research must be performed to determine if, or which, EOs exhibit antimicrobial qualities against *Campylobacter* that may also simultaneously support GIT bacteria that are antagonistic to *Campylobacter*. While EOs do not appear to operate as substrates for *Lactobacillus* or other probiotics and are therefore not prebiotics, their indirect impacts on the intestinal mucosal layer promote an environment suitable for the growth of "beneficial" bacteria, which in turn, have the potential to reduce *Campylobacter* concentrations. Other studies found that EOs, including cumin, orange oil, and oregano, have an inhibitory effect on *Lactobacillus* spp. ([@B159]; [@B81]; [@B62]; [@B43]). As such, there are limitations for the application of EOs to poultry that must be addressed.

Potential Limitations and Future Directions for Preharvest EOs Application
--------------------------------------------------------------------------

There appears to be inconsistency in responses of birds infected by *Campylobacter* when administered EOs compared to *in vitro* responses as well as among individual bird trials. Understanding the underlying factors and potential limitations may give insight into how EOs can be applied in the future. One primary limitation of EOs is that they can be rapidly absorbed in the GIT ([@B195]). This rapid absorption has been observed in pigs and humans ([@B161]; [@B195]). Absorption by the stomach and small intestine before they can affect cecal concentrations may be occuring in *in vivo* studies ([@B10]). To test this potential limitation, intestinal absorption resistant EOs derivatives can be applied. Thymol-β-d-glucopyranoside is more resistant to intestinal absorption than thymol and has been shown to have similar antimicrobial effects *in vitro* ([@B83]). However, while a 1 log reduction of *Campylobacter* was observed in the crops of market-aged broilers with this absorption-resistant compound, no significant impacts were found in the ceca with either thymol-based treatment ([@B83]).

Microencapsulation may also be utilized ([@B35]). Microencapsulation is a process in which liquid particles are surrounded in polymeric compounds ([@B17]). Typical water-soluble coating materials can include gelatin, gum arabic, and polyacrylic acid ([@B148]). The intention of microencapsulation with preharvest remediation techniques is to prevent the therapeutic compound from absorption before reaching the target area within the GIT ([@B296]). For instance, [@B226] found that encapsulated thymol inhibited pathogens more effectively in milk due to enhanced solubility. As such, microencapsulated EOs have been suggested as a methodology for improving the *in vivo* effects of EOs ([@B35]). Utilizing a feed-based microencapsulated blend of thymol and eugenol, along with propionic and sorbic acids, [@B107] was able to reduce *C. jejuni* in layer hens. During a 42-day trial, birds were provided this blend, labeled CTR, at varying concentrations (0.1, 0.3, 0.5, or 1.0%), and were infected with 10^7^ CFU/mL *C. jejuni* on day 22. *Campylobacter* concentrations were measured by plating cecal contents onto modified Charcoal-Cefoperazone-Deoxycholate Agar (mCCDA). The CTR blend was effective in reducing *C. jejuni* at all concentrations (0.1, 0.3, 0.5, or 1.0%) on days 35 and 43, with 1% CTR exhibiting a 5 log CFU/g reduction at day 42 compared to the control. At day 42 the 0.1% concentration reduced *Campylobacter* populations by 3 log CFU/g. In a second experiment utilizing either 0.1 or 0.3% of this blend, birds were given either the blend before or after the day 22 infection with *Campylobacter*. Statistically significant reductions were still observed within each treatment group, except with 0.1% CTR at day 35, but the reductions were significantly lower for the group given the treatment after infection instead of before. The CTR blend at a concentration of 0.3% given from day 0 to 21 reduced *C. jejuni* by 1.5 log CFU/g at day 35 where 3 log CFU/g reductions were observed when the 0.3% CTR blend was applied on day 22. However, in a cecal loop model study by [@B124], involving direct injection of the trans-cinnamaldehyde into ceca infected with *C. jejuni* they failed to detect significant reductions in *Campylobacter* concentrations. This indicates that the absorption of the EOs in the upper GIT is not the only reason for variation between *in vivo* and *in vitro* trials ([@B10]). Further experiments utilizing microencapsulation of combined EO blends, along with comparisons with their unencapsulated counterparts, is necessary to determine the specific effectiveness of utilizing microencapsulation.

Additionally, the observed reductions using blends of EOs can help reduce the incidence of *Campylobacter* at time of slaughter, which can lead to reductions of human incidences of campylobacteriosis ([@B246]; [@B45]). Furthermore, an investigation into EOs impact on the GIT microbiome may also represent a pertinent future direction. For instance, increasing the concentrations of certain members of the GIT microbiome through EOs may generate a GIT less suitable or more hostile for initial *C. jejuni* colonization ([@B149]). Once the interactions between *C. jejuni*, the microbiome, and EOs remediation are fully elucidated a more targeted remediation technique may be possible. For instance, specific EOs blends could be designed to modulate the microbiome to prevent *C. jejuni* colonization. While *in vivo* EOs application may not be able to eliminate *Campylobacter* concentrations at the time of slaughter, it does provide a hurdle that the bacteria must overcome before contamination of the final product ([@B178]; [@B129]).

Antimicrobial Effects of EOs on *Campylobacter* in Poultry Processing
=====================================================================

*Campylobacter* contamination on poultry products is one of the more common causes of campylobacteriosis in humans ([@B153]). Incidence rates in a study of 425 broiler carcasses over 12 months revealed 87.5% of the post-chill carcasses were contaminated with *Campylobacter* in a French slaughterhouse ([@B132]). In the United States, 52% of post-chill carcasses (*n* = 325) were contaminated with *Campylobacter* with 100% of the carcasses being contaminated pre-chill ([@B268]). The most frequent method for this contamination event is for the GIT to rupture during processing and contaminants to spill onto the carcass ([@B26]). If not properly treated during carcass rinses, cross-contamination can occur, especially within chiller tanks ([@B19]). As such, to prevent cross-contamination, it is vital that carcass rinses and sprays be applied as appropriate sanitation techniques. Essential oils may serve as an alternative sanitizer for processing washes.

*In vitro* laboratory experiments may have more relevance to post-harvest interventions than pre-harvest mediations due to the complexity of the poultry GIT that cannot easily be modeled in a laboratory environment ([@B310]). For instance, in a series of benchtop studies orange oil was found to be inhibitory to *C. jejuni, C. coli, L. monocytogenes, Salmonella*, and *Pseudomonas* ([@B220]; [@B210]; [@B43]). [@B210] tested seven orange oil fractions on 3 *Arcobacter* strains and 21 *Campylobacter* strains, including 14 *C. jejuni* strains, four of which were isolated from poultry. When viewed on disk diffusion agar, cold pressed (CP) terpeneless Valencia orange oil produced the largest zones of inhibition (in mm) of *C. jejuni* including those isolated in poultry, whereas other orange oil fractions produced more limited zones of inhibition. Valencia orange oil was also reported to be inhibitory toward *C. coli* and *Arcobacter*. [@B169] found tea tree oil at a concentration of 0.001% to be inhibitory against two strains of *C. jejuni* on nutrient agar. Wild carrot oil, when used in agar plates as an antimicrobial against *Campylobacter* spp. including a multidrug-resistant strain, *C. jejuni* 99T403, exhibited a minimum inhibitory concentration (MIC) of 125 to 500 μg/mL depending on the species or strain ([@B247]). Isoeugenol and E-methyl isoeugenol are extracts of carrot oil and when tested against *C. jejuni* resulted in an MIC of 125 μg/mL ([@B247]). Thymol, in a concentration of 0.25 μmol/mL, reduced *C. jejuni* and *C. coli* by 5 logs CFU/mL in Bolton broth from an initial concentration of 7 log CFU/mL ([@B8]; [@B36]). An EO extract from *Origanum minutiflorum*, composed primarily of carvacrol and *p-*cymene, has been shown to be effective in inhibiting *C. jejuni* in concentrations as low as 12.5 μg/mL on Mueller-Hinton agar ([@B11]). However, these MICs were strain-specific, as of the 12 *C. jejuni* strains tested, only *C. jejuni* 118d was inhibited at the concentration of 12.5 μg/mL, while *C. jejuni* 113k, 7d, and 9a required 700 μg/mL to be inhibited ([@B11]). Cinnamon, clove, thyme, and bay leaf oils were found to be bacteriostatic at a concentration of 0.075% against *C. jejuni, S.* Enteritidis*, E. coli, Staphylococcus aureus*, and *L. monocytogenes* when tested in tryptic soy broth (TSB) ([@B267]).

Other studies reported similar inhibitory and bacteriostatic effects of oregano, eucalyptus, marigold, ginger, jasmine, cedarwood, carrot, mugwort, bergamot, and other EOs, against *Campylobacter* and other foodborne pathogens ([@B97]; [@B204]; [@B91]; [@B277]). The MIC of EOs on other foodborne pathogens were collected and reviewed in [@B134]. [@B97] tested 119 EOs against *C. jejuni, E. coli* O157:H7*, L. monocytogenes*, and *S. enterica* in PBS for 60 min at 37°C (42°C for *C. jejuni*) followed by plating on appropriate media for each species, including an iron-supplemented Brucella agar for *C. jejuni.* The EO concentration that resulted in the bactericidal activity of a 50% CFU decrease relative to the control was determined for each EO bacterial species combination. Marigold taegetes (0.003%), ginger root (0.005%), jasmine (0.006%), patchouli (0.007%), and gardenia (0.007%) were the most effective oils against *C. jejuni* RM1221 followed by cedarwood (0.0075%), carrot seed (0.0078%), celery seed (0.0085%), mugwort (0.009%), spikenard (0.009%), and orange bitter oils (0.009%). In this study, 39 EOs were tested against all four foodborne pathogens. When their bactericidal activities were averaged, the five most effective EOs were cinnamaldehyde (0.03%), thymol (0.05%), Spanish oregano (0.05%), carvacrol (0.06%), and *Oregano origanum* (0.06%). Of these five EOs, *C. jejuni* was impacted the most by the lowest percent concentration compared to the other tested foodborne pathogens.

This suggests that not only may *C. jejuni* be a prime target for EO remediation, but EO that have not been extensively tested may be more optimal candidates to utilize, such as marigold and jasmine. Disk diffusion methods indicated that lemon, sweet orange and bergamot were effective against *L. monocytogenes, S. aureus, B. cereus, E. coli* O157:H7, and *C. jejuni* ([@B91]). Each oil was added to a 2 cm disk and then placed on agar plates in the presence of the bacteria of interest, with *C. jejuni* SR 117 being plated on *Campylobacter* agar base with 5% horse blood and incubated at 42°C. No zones of inhibition were detected for *C. jejuni* when orange or citral was added. Bergamot produced a zone of inhibition of 23 mm, and lemon produced a zone of inhibition of 18 mm, which were the smallest zones compared to the other tested bacteria. The zone of inhibition for linalool was greater than 90 mm. The MIC was also determined for bergamot (greater than 4%), lemon (greater than 4%), and linalool (0.06%). While no zone of inhibition was visually detected for orange oil by [@B91], when orange oil was supplemented with thyme, the combination EOs demonstrated antimicrobial activity against *Campylobacter* ([@B277]). Similar to [@B91], a disk diffusion test was performed using thyme, orange, rosemary, clove, and a 1:1 ratio of thyme and orange oil. This was tested on *C. jejuni* 11601 MD, *C. jejuni* RM1221, and *C. coli* RM2228 along with a cocktail of the three strains. No visible growth on disk diffusion assay across all strains and in the cocktail was visualized when exposed to thyme or clove. For the cocktail, orange oil, rosemary, and the combination of thyme and orange oil produced zones of inhibition of 17, 11, and 20 mm, respectively. A macro-broth dilution assay was also performed using Mueller Hinton broth to determine the MIC and minimum bactericidal concentration (MBC) of these oils. However, the exact MIC and MBC was not determined as 0.0008% concentrations of the oils were sufficient for inhibiting bacterial growth.

Synergistic effects have also been detected ([@B217]). For instance, a combination of oregano and thyme or oregano and cinnamaldehyde required 80% less EOs to produce the same inhibitory effects in nutrient broth with a *Campylobacter* growth supplement ([@B214]). Thymol and geraniol reduced *Clostridium difficile* in feces at 500 ppm, which was five times the concentration utilized for a significant reduction in pure cultures. When 0.16 mg/mL of rosemary oil, consisting of carnosic acid, carnosol, and rosmarinic acid was applied in the laboratory, a 2 log CFU/mL reduction in *C. jejuni* was observed in Mueller-Hinton broth when the initial concentration was at 7 log CFU/mL ([@B160]; [@B234]). However, four times the concentration was needed to achieve the same reduction in chicken meat juice, isolated from thawed previously frozen carcasses, unless supplemented with nisin, a bacteriocin ([@B234]). While the complete composition was not provided in [@B234], it was suggested that lipids and proteins within the juice matrix might have partly inhibited the EO therapy. [@B31] suggested that the decreased EO effectiveness in the food matrix compared to the broth experiment may be because in an oil-in-water emulsion that allows the bacteria to grow as films and in colonies, which can shield interior cells from therapeutics. As a consequence, while *in vitro* laboratory models are important, to elucidate the potential impact of EOs, poultry product matrices as well as processing environments must be considered.

The use of EOs in the post-harvest environment has focused on their bactericidal activity within carcasses washes and finished products ([@B35]; [@B68]). A 0.5% 50:50 mixture of thyme oil and orange oil was used in a marinade for chicken wings dip-inoculated with 10^7^ CFU/mL of a nalidixic acid resistant strain of *C. coli* ([@B278]). While cross-contamination events were observed via the marinade, *C. coli* concentrations on treated wings were reduced by 3.0 log CFU/mL, as determined through plating of rinsates. Skinless chicken breasts experimentally infected with 5 × 10^5^ CFU/g of *C. jejuni* were subjected to stinkwort (0.2%; *Inula graveolens*), bay leaf (0.6%; *Laurus nobilis*), mastic tree (0.6%; *Pistacia lentiscus*), and winter savory (0.6%; *Atureja gontana*) ([@B71]). After 8 days of refrigerated storage under microaerophilic conditions, greater than 5 log CFU/g reductions of *C. jejuni* were observed compared to the control inoculated with 5 × 10^5^ CFU/g. Sensory analysis indicated these EOs improved or did not impact the odor of the refrigerated samples according to a six member trained panel. Within 60 s, 0.06% linalool oil reduced *C. jejuni* on 2 cm × 2 cm pieces of cabbage leaf and chicken skin by greater than 5 log CFU and 2 log CFU, respectively ([@B91]). Cold pressed Valencia orange oil has also been shown to reduce *C. jejuni* UAF 244 on retail chicken thighs and legs ([@B210]). Chicken thighs and legs were dipped in a 0.8% saline solution containing 10^6^ CFU/mL *C. jejuni* UAF 244 for 5 min and then submerged for 2 min in 20% (v/v) Valencia orange oil or 20% (v/v) limonene. The samples were then rinsed and plated. Across both types of chicken pieces, 1.5 to 2 log CFU/mL reductions were observed, compared to the control. Treatments with limonene resulted in reductions without detectable recovery of viable bacterial cells, although the limit of detection was not provided by the authors. Moreover, while taste panels have found concentrations of orange oil up to 0.1% to be acceptable in milk, chicken patties and marinades, a 20% part dip has not been investigated for impacts on sensory characteristics ([@B142]; [@B89]; [@B244]).

Other factors may confound EO efficacy toward *Campylobacter* in poultry products. For example, one major concern for poultry industries is the ability for pathogens to form biofilms ([@B269]). Biofilms are bacterial communities within a polysaccharide matrix that can readily form and attach on processing surfaces ([@B54]; [@B72]). Biofilms can be difficult to remove by antimicrobials and processing sanitizers such as chlorine and peracetic acid, which are commonly used in the industry ([@B93]; [@B251]; [@B256]; [@B60]). *Campylobacter* is known to form biofilms on stainless steel, polystyrene, and glass ([@B112]). Coriander oil and its antimicrobial component linalool were found to affect biofilm formation of *Campylobacter* planktonic cells and pre-established biofilms ([@B74]). When coriander and linalool were used at 2 μg/mL (approximately four times the MIC) *C. jejuni* and *C. coli* biofilms were reduced in size by 70 to 80% after 48-h incubation in a crystal violet assay ([@B75], [@B74]). Even when using half the MIC, coriander, and linalool reduced the biofilm by 20 to 25% ([@B74]). Results of biofilm inhibition varied more wildly from planktonic cells, but all concentrations (0.025 to 2 μg/mL) successfully inhibited biofilm growth compared to the control, with linalool reducing some biofilm formation between 10 and 20% of the control ([@B74]). Thyme, oregano, and cinnamon EOs, when used at concentrations below the MIC, were also found effective against biofilms of *Acinetobacter, Sphingomonas*, and *Stenotrophomonas* spp. that were isolated from biofilms within the food industry ([@B276]). *Sphingomonas* biofilms were reduced by 50% by thyme oil at a concentration of 0.001% where the MIC was 0.008% ([@B276]). Similar results were found using thyme and balsam on *Pseudomonas* and *S. aureus* biofilms ([@B152]; [@B155]).

Conclusions
===========

The effectiveness of EOs in poultry has not been clearly defined yet. Product advantages have been noted in several studies, but studies also exist that display no impact on FCR or BWG. Other advantages of EOs include the potentially improved flavor of the carcass, antioxidant capacity, and improved feed digestibility. There is also evidence that EOs can be utilized *in vitro* to impact pathogen concentrations, including *Campylobacter*. However, this depends largely on the EO utilized as the mechanism(s) of action are not well-defined. With over 300 commercially available EOs, precisely elucidating the underlying mechanisms may prove difficult ([@B14]). Less information is available regarding the mechanistic role of EOs used *in vivo*. Their potential ability to improve amino acid absorption in the ileum may allow for generating a GIT environment unfavorable to *Campylobacter* in the ceca due to diminished substrate availability, which is further downstream. To fully elucidate the impact EOs have on *Campylobacter* concentrations *in vivo*, further research on the mechanism(s) and effects of EOs must be performed.

More targeted delivery of EOs to certain sites in the avian GIT may be warranted as well. Microencapsulation may help to stabilize the chemical activity of the EO until it reaches its target site in the GIT, thus ensuring less variability. Microencapsulation also holds promise in addressing the intestinal absorption of an antimicrobial. However, investigations into the duration the encapsulated EOs remains in the GIT need to be performed to see when the remediation should be administered. In post-harvest settings, further studies should be performed involving the addition of EOs to sprays, washes, or within the chiller tank.

To determine the specific antimicrobial effects of EOs, the mechanism(s) must be elucidated. This is essential because, with a wide variety of EOs, there may be multiple mechanisms at work and thus synergistic potential which cannot be determined without proper identification of the mode of inhibitory action for each individual EO. Toward this effort, molecular approaches such as transcriptomics and proteomics may be employed to determine which pathways EOs inhibit will lead to further understanding of their impact on *Campylobacter.* While there have been suggestions to utilize EOs as a hurdle technology in poultry production pre- and post-harvest, mechanisms of action against *Campylobacter* and the optimal GIT locations and processing steps must first be established before any practical recommendations can be given.
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